Virological failures and genotypic resistance in children and adolescents randomised to dolutegravir-based ART vs. standard-of-care in the main ODYSSEY trial (≥14kg)

Authors: White E and Kityo C on behalf of the ODYSSEY trial team

Presented at: CHIVA 2021